维普期刊资源整合服务平台（V6.5）

49篇 您的检索式：作者名="SOSMAN J"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Treatment of metastatic renal cell carcinoma with a combination of bevacizu-nab and erlotinib显示文摘	Hainsworth J D Sosman J A Spigel D R	2005	J Clin Oncol2005，23，31：	1
2	Phase I/II trial of tremelimumab in patients with metastatic melanoma显示文摘	Camacho LH Antonia S Sosman J	2009	J Clin Oncol2009，27，7：	1
3	Concurrent phase Ⅰ trials of intravenous interleukin 6 in solid tumor patients: reversible dose-limiting neurological toxicity 显示文摘	Sosman J A Aronson F R Sznol M	1997	Clin Cancer Res1997，3，1：	1
4	Food-dependent exercise- induced anaphylaxis显示文摘	Kidd J M Cohen S H Sosman A J	1983	Allergy Clin I mmunol1983，，71：	1
5	A randomized phase 2 study of etaracizumab, a monoclonal antibody against integrin alpha (v) beta (3), + or - dacarbazine in patients with stage IV metastatic melanoma显示文摘	Hersey P Sosman J O'Day S	2010	Cancer2010，116，6：	1
6	Phase I/II trial of tremelimumab in patients with metastatic melanoma 显示文摘	Camacho LH Antonia S Sosman J	2009	J Clin Oncol2009，27，7：	1
7	A randomized phase 2 study of etaracizumab,a monoclonal antibody against integfin αvβ3,+or-dacarbazine in patients with stage Ⅳ metastatic melanoma显示文摘	Hersey P Sosman J O'Day S		0，，：	1
8	The major genetic determinants of HIV-1control affect HLA class I peptide presentation显示文摘	International HIV Controllers Study Pereyra F Jia X McLaren P J Telenti A de Bakker P I Walker B D Ripke S Brumme C J Pulit S L Carrington M Kadie C M Carlson J M Heckerman D Graham R R Plenge R M Deeks S G Gianniny L Crawford G Sullivan J Gonzalez E Davies L Camargo A Moore JM Beattie N Gupta S Crenshaw A Burtt N P Guiducci C Gupta N Gao X Qi Y Yuki Y Piechocka-Trocha A Cutrell E Rosenberg R Moss K L Lemay P O'Leary J Schaefer T Verma P Toth I Block B Baker B Rothchild A Lian J Proudfoot J Alvino D M Vine S Addo M M Allen T M Altfeld M Henn M R Le Gall S Streeck H Haas D W Kuritzkes D R Robbins G K Shafer R W Gulick R M Shikuma C M Haubrich R Riddler S Sax P E Daar E S Ribaudo H J Agan B Agarwal S Ahern R L Allen B L Altidor S Altschuler E L Ambardar S Anastos K Anderson B Anderson V Andrady U Antoniskis D Bangsberg D Barbaro D Barrie W Bartczak J Barton S Basden P Basgoz N Bazner S Bellos N C Benson A M Berger J Bernard N F Bernard A M Birch C Bodner S J Bolan R K Boudreaux E T Bradley M Braun J F Brndjar J E Brown S J Brown K Brown S T Burack J Bush LM Cafaro V Campbell O Campbell J Carlson R H Carmichael J K Casey K K Cavacuiti C Celestin G Chambers S T Chez N Chirch L M Cimoch P J Cohen D Cohn LE Conway B Cooper D A Cornelson B Cox D T Cristofano M V Cuchural G Jr Czartoski J L Dahman J M Daly J S Davis B T Davis K Davod S M DeJesus E Dietz C A Dunham E Dunn M E Ellerin T B Eron J J Fangman J J Farel C E Ferlazzo H Fidler S Fleenor-Ford A Frankel R Freedberg K A French N K Fuchs JD Fuller J D Gaberman J Gallant J E Gandhi R T Garcia E Garmon D Gathe J C Jr Gaultier C R Gebre W Gilman F D Gilson I Goepfert P A Gottlieb M S Goulston C Groger R K Gurley T D Haber S Hardwicke R Hardy W D Harrigan P R Hawkins T N Heath S Hecht F M Henry W K Hladek M Hoffman R P Horton J M Hsu R K Huhn G D Hunt P Hupert M J Illeman M L Jaeger H Jellinger R M John M Johnson J A Johnson K L Johnson H Johnson K Joly J Jordan W C Kauffman C A Khanlou H Killian R K Kim A Y Kim D D Kinder C A Kirchner J T Kogelman L Kojic E M Korthuis P T Kurisu W Kwon D S LaMar M Lampiris H Lanzafame M Lederman M M Lee D M Lee J M Lee M J Lee E T Lemoine J Levy J A Llibre J M Liguori M A Little S J Liu A Y Lopez A J Loutfy M R Loy D Mohammed D Y Man A Mansour M K Marconi V C Markowitz M Marques R Martin J N Martin H L Jr Mayer K H McElrath M J McGhee T A McGovern B H McGowan K McIntyre D Mcleod GX Menezes P Mesa G Metroka CE Meyer-Olson D Miller A O Montgomery K Mounzer K C Nagami E H Nagin I Nahass R G Nelson M O Nielsen C Norene D L O'Connor D H Ojikutu B O Okulicz J Oladehin O O Oldfield E C Olender S A Ostrowski M Owen WF Jr Pae E Parsonnet J Pavlatos A M Perlmutter A M Pierce M N Pincus J M Pisani L Price L J Proia L Prokesch R C Pujet H C Ramgopal M Rathod A Rausch M Ravishankar J Rhame F S Richards C S Richman D D Rodes B Rodriguez M Rose R C 3rd Rosenberg E S Rosenthal D Ross P E Rubin D S Rumbaugh E Saenz L Salvaggio M R Sanchez WC Sanjana V M Santiago S Schmidt W Schuitemaker H Sestak P M Shalit P Shay W Shirvani V N Silebi V I Sizemore J M Jr Skolnik P R Sokol-Anderson M Sosman J M Stabile P Stapleton J T Starrett S Stein F Stellbrink H J Sterman FL Stone V E Stone D R Tambussi G Taplitz R A Tedaldi E M Telenti A Theisen W Torres R Tosiello L Tremblay C Tribble M A Trinh P D Tsao A Ueda P Vaccaro A Valadas E Vanig T J Vecino I Vega V M Veikley W Wade B H Walworth C Wanidworanun C Ward D J Warner D A Weber R D Webster D Weis S Wheeler D A White D J Wilkins E Winston A Wlodaver C G van't Wout A Wright D P Yang O O Yurdin D L Zabukovic B W Zachary K C Zeeman B Zhao M	2010	Science2010，330，6010：	1
9	A phase I/II study of sequential interleukin-3 and granulocyte- macrophage colony-stimulating factor in myelodysplastic syndromes显示文摘	NAND S SOSMAN J GODWIN J E	1994	Blood1994，83，：	1
10	Combination targeted therapy in advanced renal cell carcinoma显示文摘	Sosman J Puzanov I	2009	Cancer2009，，：	1
11	Phase Ⅰ study of PLX4032: Proof of concept for V600E BRAF mutation as a therapeutic target in human cancer 显示文摘	Puzanov J Sosman K Flaherty I	2009	J Clin Oncol2009，27，15：	1
12	Treatment of metastatic renal cell carcinoma with a combination of bevacizumab and Erlotinib显示文摘	Hainsworth J D Sosman J A Spigel D R	2005	J Clin Oncol2005，23，31：	1
13	New spectroscopic results of trivalent chromium in magnesium gallate显示文摘	SOSMAN L P FONSECA R J M TAVARES J A D	2007	Journal of Physics and Chemistry of Solids2007，68，1：	1
14	Survival in BRAF V600- mutant advanced melanoma treated with vemurafenih显示文摘	Sosman J A Kim K B Sehuehter L	2012	New England Journal of Medicine2012，366，8：	1
15	A randomized phase 2 study of etaracizumab, a monoclonal antibody against integrin alpha(v)beta(3), + or-dacarbazine in patients with stage IV metastatic melanoma 显示文摘	Hersey P Sosman J O'Day S	2010	Cancer2010，116，6：	1
16	Phase Ⅰ/Ⅱ trial of treme- limumab in patients with metastatic melanoma 显示文摘	Camacho L H Antonia S Sosman J	2009	J Clin Oncol2009，27，7：	1
17	Clinical activity,safety,and biomarkers of MPDL3280A,an engineered PD-L1 antibody in patients with metastatic melanoma 显示文摘	HAMID O SOSMAN J A LAWRENCE D P	2013	J Clin Oncol2013，，：	1
18	BEAM : A randomized phase Ⅱ study evaluating the activity of BEvacizumab in combination with carboplatin plus paclitaxel in patients with previously untreated advanced melanoma 显示文摘	O'Day SJ Kim K sosman J	2009	Ann Oncol2009，，：	1
19	Survival in BRAF V600- mutant advanced melanoma treated with vemurafenib显示文摘	Sosman J A Kim K B Schuchter L	2012	N Engl J Med2012，366，8：	1
20	Results of clinical trials with an allogeneic melanoma tumor cell lysate vaccine: Melacine 显示文摘	Sondak V K Sosman J A	2003	Semin Cancer Biol2003，13，：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示